Genomic Prostate Score (GPS)

About MDxHealth

MDxHealth is a Belgium-based, publicly traded company that develops and commercializes molecular diagnostic tests for urologic diseases, with a primary focus on prostate cancer. The company leverages proprietary genetic, epigenetic, and complex molecular technologies to offer a suite of tests that address key clinical decision points, from initial risk assessment to post-treatment monitoring. Having impacted over 500,000 patients, MDxHealth operates as a commercial-stage entity with tests like ConfirmMDx and GPS, and is expanding its menu with new additions like the ExoDx Prostate Test.

Therapeutic Areas